All the Active Ingredient Drugs
Protein Kinase Inhibitor. Cobimetinib Hemifumarate 20 mg. F.C. TABS.:63.
60 mg (3 tabs. of 20 mg) once dly., taken on a 28 day cycle. 21 consecutive d. (1st -21st day -tmt. period); follow.by a 7-day break (22nd -28th –tmt. break). Each subseq. tmt. cycle should start after the 7-day tmt. break has elapsed. See lit.
Indicat. for use in comb. with vemurafenib for the tmt. of adult pts. with unresectab. or metastat. melanoma with a BRAF V600 mutation.